Overview

CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)

Status:
Active, not recruiting

Trial end date:
2022-12-31

Target enrollment:
0

Participant gender:
Female

Summary

Postnatal depression affects about 10-15% of women after childbirth. Approximately 3-5% of women experience a moderate-to-severe depression that requires medical attention. This study aims to investigate the implication of pain relief choice in reducing the postnatal depression of women who deliver their babies.

Phase:

Phase 2/Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

KK Women's and Children's Hospital

Treatments:

Entonox
Fentanyl
Meperidine
Nitrous Oxide
Remifentanil
Ropivacaine

Criteria

Inclusion Criteria:

- Healthy adult (American Society of Anesthesiologists physical status 1 and 2)
parturients at term (36 weeks gestation or more) (nulliparous and multiparous);

- With a singleton fetus.

Exclusion Criteria:

- Multiple pregnancies;

- Non-cephalic fetal presentation;

- Obstetric complications (e.g. pre-eclampsia, uncontrolled hypertension, uncontrolled
diabetes);

- Elective and urgent caesarean section (not from delivery suite).